Embase webinar - An introduction 17 July 2012
-
Upload
ann-marie-roche -
Category
Health & Medicine
-
view
592 -
download
0
Transcript of Embase webinar - An introduction 17 July 2012
Embase for biomedical searching: An introduction
Your host: Chris Flemming Your presenter: Derrick Umali
Welcome to our Embase webinar!
About us
• Webinar control panel:
• ‘chat’ or ‘ask a question’ for questions
and comments• Option for full screen view
• Q&A after presentation
Need to know
4
Embase is the world’s most comprehensive, intelligent biomedical research tool, providing the drug and drug-related research community with reliable and authoritative content, to advance new biomedical and pharmaceutical discovery.
ConfidenceFind all relevant articles that may not otherwise be found by alternative databasesDeep biomedical indexing All relevant, up-to-date, biomedical information from the research literaturePrecise retrievalDeep and focused research through powerful retrieval tools
What is Embase
CONFIDENCE
5
Emtree: Biomedical thesaurus, over 60k terms
Embase: Fully indexed: Over 7,900 journals (including MEDLINE), 1950-
MEDLINE: Over 2,500 journals unique to Embase, mapped to
Embase indexing, 1950- (including MEDLINE Classic)
Embase Classic:
Digitally scanned and
re-indexed, 1947-1973
AIP and In Process:
Indexing added, from 2009
Conference Abstracts:
Indexing added, from 2009
1947 1950 1974 2009
Content Overview
Embase.com journal overview 2012
Indexed by Embase (5396 titles)Indexed by MEDLINE
(5592 titles)
2368 journals
Indexed at Embase
Unique to Embase
Search:
[embase]/lim
3028 journals
Indexed at Embase
Also covered by MEDLINE
Search:
[embase]/lim AND [medline]/lim
2564 journals*
Indexed by MEDLINE
Also in MEDLINE
Search:
[medline]/lim NOT
[embase]/lim
Embase.com covers 7960 journals (20 March 2012)
* Converted to Embase format as described in the “Coverage of MEDLINE in Embase” white paper (May
2011)
Embase scope and coverage (2012)
Other topics 28%
Including public health, basic biomedical science and topics
included from MEDLINE
Embase vs MEDLINE scope
Similar overall pattern of coverage... but with two major differences1. Pharmacology and toxicology: Embase: 11.2% (889 titles)MEDLINE: 8.3% (465 titles)Clinical Medicine Insights: Therapeutics New ZealandAfrican Journal of Pharmacy and Pharmacology NigeriaAnales de la Real Academia Nacional de Farmacia SpainAnkara Universitesi Eczacilik Fakultesi Dergisi TurkeyArhiv za Farmaciju Serbia
2. General clinical medicineEmbase: 10.5% (835 titles)MEDLINE: 8.9% (495 titles)
Salud(i)Ciencia ArgentinaSalus VenezuelaSapporo Medical journal JapanScientia Medica BrazilScientific Journal of Kurdistan University of Medical Sciences Iran
Topic area Elsevier (total)
UniqueEmbase
Shared(both)
UniqueMEDLINE
MEDLINE(total) TOTAL
Allergy & Immunology 249 78 171 15 186 264
Cardiovascular Medicine 321 132 189 19 208 340
Medicinal Chemistry & Drug Discovery 150 72 78 0 78 150
Neurology 331 128 203 51 254 382
Oncology 348 142 206 27 233 375
Pharmaceutical Science 213 150 63 13 76 226
Pharmacology 553 271 282 33 315 586
Embase WITH MEDLINE
Conference Abstracts
11
• Coverage began in 2009.
• Check http://embase.com/info/what-is-embase/coverage for the most up to date list of conference abstracts and conferences covered.
DEEP INDEXING
12
60K terms (>260,000 synonyms) and all MeSH terms
Over 30K drug and chemical terms
What is mapping?
Mapping means that searchers get the same results
regardless of which term they use, e.g. Vioxx (synonym) or rofecoxib (the
preferred term).
Updated 3 times a year (back-posting each time)
All drug generic names described by FDA and EMA, all International Non-Proprietary Names (INNs) described by WHO from 2000.
Deep indexing - Emtree
14 study types, including NEW Diagnostic Test Accuracy Study
78 drug and disease subheadings
Deep indexing - Emtree
PRECISE RETRIEVAL
Start searching…
Find the best terms for your search and include synonyms automatically with
autocomplete in Quick Search
Click on Disease Filter for example, to see which diseases are referenced with Januvia, either as a therapeutic area or side effect.
Find deep drug and disease relationships without having to consult the full text.
Registering in Embase
19
•Setting up email alerts
•Saving your searches
•Staying up to date
Poll
The poll should appear on your screen shortly...
Let’s take a look at Embase...
• Building and combining searches• Refining your search• Setting up email alerts and saving your searches
Building and combining searches
• Use single quotes to capture a phrase ‘diabetes mellitus’ for example (not with Autocomplete in Quick Search)
• Break up your search into individual searches, such as a drug search (in Drug Search form) and a disease search (in Disease Search form) and combine your results in Session Results
• Run your cursor over your search to Edit or copy to a Search Form for guided editing.
• Truncation and operators, AND, OR, NOT, NEXT, NEAR
Refer to http://info.embase.com/helpfiles for more guidance and links to materials such as the Quick User Guide.
Refining your search
• Quick and Advanced Limits on Advanced, Drug and Disease Search forms
• Major Focus on all advanced forms – major drugs and diseases retrieved
• Field limits under Advanced Search box to search in specific fields such as article title, abstract, conference name, drug name etc
• Drug and Disease Subheadings to limit to specific concepts such as Adverse Drug Reaction, Drug Comparison and Side Effect.
• Filters on Session Results page for specific diseases or study types for example
Check out our training videos at www.trainingdesk.elsevier.com/embase for more guidance.
Registering in Embase
24
•Setting up email alerts
•Saving your searches
•Staying up to date
Questions & Answers
• Q&A will be sent to you by email.• For more information and questions please contact
[email protected]• Visit the training calendar for more webinars -
http://trainingdesk.elsevier.com/events/calendar/2012• Go to www.trainingdesk.elsevier.com/embase for all
training related materials
Please fill out the survey that appears on your
screen after leaving the webinar.